ATE254632T1 - Neue salzformn von (2e)-5-amino-5-methylhex-2- enolsäure n-methyl-n-((1r)-1-(methylcarbamoyl)-2- phruylrthyl) carbamoyl)-2-(2-naphtyl)ethyl)amid - Google Patents

Neue salzformn von (2e)-5-amino-5-methylhex-2- enolsäure n-methyl-n-((1r)-1-(methylcarbamoyl)-2- phruylrthyl) carbamoyl)-2-(2-naphtyl)ethyl)amid

Info

Publication number
ATE254632T1
ATE254632T1 AT99937933T AT99937933T ATE254632T1 AT E254632 T1 ATE254632 T1 AT E254632T1 AT 99937933 T AT99937933 T AT 99937933T AT 99937933 T AT99937933 T AT 99937933T AT E254632 T1 ATE254632 T1 AT E254632T1
Authority
AT
Austria
Prior art keywords
methyl
methylcarbamoyl
carbamoyl
ethyl
amino
Prior art date
Application number
AT99937933T
Other languages
English (en)
Inventor
Claus Ulrik Jessen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE254632T1 publication Critical patent/ATE254632T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
AT99937933T 1998-03-03 1999-02-26 Neue salzformn von (2e)-5-amino-5-methylhex-2- enolsäure n-methyl-n-((1r)-1-(methylcarbamoyl)-2- phruylrthyl) carbamoyl)-2-(2-naphtyl)ethyl)amid ATE254632T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK28298 1998-03-03
PCT/DK1999/000089 WO1999045029A1 (en) 1998-03-03 1999-02-26 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide

Publications (1)

Publication Number Publication Date
ATE254632T1 true ATE254632T1 (de) 2003-12-15

Family

ID=8091813

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99937933T ATE254632T1 (de) 1998-03-03 1999-02-26 Neue salzformn von (2e)-5-amino-5-methylhex-2- enolsäure n-methyl-n-((1r)-1-(methylcarbamoyl)-2- phruylrthyl) carbamoyl)-2-(2-naphtyl)ethyl)amid

Country Status (15)

Country Link
EP (1) EP1060190B1 (de)
JP (1) JP2002505340A (de)
KR (1) KR20010041533A (de)
CN (1) CN1291994A (de)
AT (1) ATE254632T1 (de)
AU (1) AU3247899A (de)
BR (1) BR9908399A (de)
CA (1) CA2322051A1 (de)
DE (1) DE69912930D1 (de)
HU (1) HUP0100998A3 (de)
IL (1) IL137353A0 (de)
PL (1) PL342706A1 (de)
TW (1) TW538047B (de)
WO (1) WO1999045029A1 (de)
ZA (1) ZA991572B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1407779A1 (de) 2002-10-10 2004-04-14 Gastrotech A/S Verwendung von Ghrelin zur Behandlung von vermindertem Körpergewicht und Körperfett in Individuen mit Gastrektomie
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
AR059066A1 (es) 2006-01-27 2008-03-12 Amgen Inc Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
CN101657436A (zh) 2007-02-09 2010-02-24 特兰齐姆制药公司 大环生长素释放肽受体调节剂及其使用方法
PL2480559T3 (pl) 2009-09-21 2013-11-29 Gilead Sciences Inc Sposoby i związki pośrednie do wytwarzania analogów 11cyjanokarbanukleozydowych
WO2012012465A1 (en) 2010-07-19 2012-01-26 Clarke, Michael, O'neil Hanrahan Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
CN103052631B (zh) 2010-07-22 2015-11-25 吉里德科学公司 用于治疗副黏病毒科病毒感染的方法和化合物
TWI687432B (zh) 2014-10-29 2020-03-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
EP3242934B1 (de) 2015-01-08 2021-08-18 The Board of Trustees of the Leland Stanford Junior University Faktoren und zellen zur bereitstellung der induktion von knochen, knochenmark und knorpel
DK3785717T3 (da) 2015-09-16 2022-03-21 Gilead Sciences Inc Fremgangsmåder til behandling af coronaviridae-infektioner
JP6824434B2 (ja) 2017-03-14 2021-02-03 ギリアード サイエンシーズ， インコーポレイテッド ネココロナウイルス感染を処置する方法
EP4219513A1 (de) 2017-05-01 2023-08-02 Gilead Sciences, Inc. Kristalline form von (s)-2-ethylbutyl 2-((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f) [1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran2-yl)methoxy)oat
CN111093627B (zh) 2017-07-11 2024-03-08 吉利德科学公司 用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物
CN114641299A (zh) 2020-01-27 2022-06-17 吉利德科学公司 用于治疗SARS CoV-2感染的方法
AU2021234308C1 (en) 2020-03-12 2024-02-22 Gilead Sciences, Inc. Methods of preparing 1'-cyano nucleosides
CA3172483A1 (en) 2020-04-06 2021-10-14 Scott Ellis Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
TW202203941A (zh) 2020-05-29 2022-02-01 美商基利科學股份有限公司 瑞德西韋之治療方法
CA3187821A1 (en) 2020-06-24 2021-12-30 Gilead Sciences, Inc. 1'-cyano nucleoside analogs and uses thereof
TW202233204A (zh) 2020-08-27 2022-09-01 美商基利科學股份有限公司 用於治療病毒感染之化合物及方法
EP4320128A1 (de) 2022-03-02 2024-02-14 Gilead Sciences, Inc. Verbindungen und verfahren zur behandlung von virusinfektionen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637855D1 (de) * 1995-12-22 2009-04-16 Novo Nordisk As Verbindungen mit wachstumshormon-freisetzenden eigenschaften

Also Published As

Publication number Publication date
AU3247899A (en) 1999-09-20
DE69912930D1 (de) 2003-12-24
JP2002505340A (ja) 2002-02-19
TW538047B (en) 2003-06-21
HUP0100998A3 (en) 2001-12-28
CN1291994A (zh) 2001-04-18
CA2322051A1 (en) 1999-09-10
BR9908399A (pt) 2000-10-31
KR20010041533A (ko) 2001-05-25
ZA991572B (en) 1999-09-03
IL137353A0 (en) 2001-07-24
WO1999045029A1 (en) 1999-09-10
PL342706A1 (en) 2001-07-02
EP1060190A1 (de) 2000-12-20
HUP0100998A2 (hu) 2001-08-28
EP1060190B1 (de) 2003-11-19

Similar Documents

Publication Publication Date Title
ATE254632T1 (de) Neue salzformn von (2e)-5-amino-5-methylhex-2- enolsäure n-methyl-n-((1r)-1-(methylcarbamoyl)-2- phruylrthyl) carbamoyl)-2-(2-naphtyl)ethyl)amid
RS82003A (en) Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereof
ME00414B (me) KRISTALI KOJI SADRŽE N-[2-(DIETILAMINO) ETIL]-5-[(5-FLUOR0-2-0KS0-3H-INDOL-3-ILIDEN)METIL]-2, 4-DIMETIL-lH-PIROL-3-KARBOKSAMID SO JABUČNE KISELINE, PROCESI ZA NJIHOVU PRIMENU I NJIHOVI PREPARATI
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
EA200400777A1 (ru) Фармацевтические композиции соединения платины
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
AU2003245804A8 (en) Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
EA200200208A1 (ru) Синергитическая композиция
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
ATE284690T1 (de) Antithrombotische diamine
HUT76511A (en) Benzoyl derivatives, preparation and use thereot
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
HRP20080660T3 (en) Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
EA200500528A1 (ru) Пиперазинил- и диазапанилбензамиды и бензтиоамиды
ATE461697T1 (de) Phospholipidderivate von valproinsäure und ihre kombinationen
UA83268C2 (en) Insecticidal agent
ATE253359T1 (de) Antithrombotische mittel
BR0012505A (pt) Composição pesticida e método para controlar pestes
DE69828522D1 (de) Antithrombotische mittel
EA200400535A1 (ru) ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
MY122588A (en) Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonylphenyl)ethyl)benzamide
RU94028126A (ru) Средство, обладающее иммуномодулирующей активностью
EA200300388A1 (ru) 1-аминоалкилциклогексаны в качестве трипаноцидных агентов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties